Skip to main content

Oncologists Accepting Curative in MassachusettsPage 2

178 verified oncologists in Massachusetts accept Curative. Profiles cover focus areas including Radiation Oncology, Medical Oncology, and Hematology & Oncology. Common hospital affiliations include Dana-Farber/Brigham and Women's Cancer Center, Brigham and Women's Hospital, and Dana-Farber Cancer Institute.

William Mayo-Smith

William Mayo-Smith, MD

Professor of Radiology

Oncology

Boston, MA30+ years
Ann Partridge

Ann Partridge, MD MPH

Chief Clinical Strategy Officer, Vice Chair of Medical Oncology, and founder and director of Young and Strong, the Program for Young Adults with Breast Can; Chair in Breast Cancer Research at Dana-Farber. She conducts clinical research focused on improving cancer care and outcomes with a particular focus on you

Oncology

Boston, MA30+ years
Jeremy Abramson

Jeremy Abramson, MD

Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School

Oncology

Boston, MA20+ years
Elizabeth Buchbinder

Elizabeth Buchbinder, M.D.

Assistant Professor of Medicine, Harvard Medical School

Oncology

Boston, MA20+ years
Jiping Wang

Jiping Wang, MD, PHD

Surgical Oncologist, Associate Professor of Surgery, Harvard Medical School

Oncology

Boston, MA30+ years
Filipa Lynce

Filipa Lynce, M.D.

Assistant Professor of Medicine, Harvard Medical School; Associate Director, Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute

Oncology

Boston, MA20+ years
Jeffrey Meyerhardt

Jeffrey Meyerhardt, MD MPH

Chief Clinical Research Officer; Director, Colon and Rectal Cancer Center

Oncology

Milford, MA20+ years
Ann Silk

Ann Silk, M.D.

Director of the Merkel Cell Carcinoma Center of Excellence; Assistant Professor of Medicine, Harvard Medical School

Oncology

Boston, MA15+ years
Neil Horowitz

Neil Horowitz, MD

Surgical Director, Gynecologic Oncology; Director, Clinical Research in Gynecologic Oncology; Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Oncology

Boston, MA30+ years
George Demetri

George Demetri, MD

Professor of Medicine, Harvard Medical School; Director, Sarcoma Center, Dana-Farber Cancer Institute; Senior Vice President for Experimental Therapeutics, Dana-Farber Cancer Institute; Co-Director, Ludwig Center at Dana-Farber/Harvard

Oncology

Boston, MA30+ years
Leif Ellisen

Leif Ellisen, MD PHD

Professor of Medicine, Harvard Medical School; Program Director, Breast Medical Oncology, Mass General Cancer Center

Oncology

Boston, MA30+ years
Irene Ghobrial

Irene Ghobrial, M.D.

Senior Vice President for Experimental Medicine, Director of the Center for Early Detection and Interception of Blood Cancers, Co-Leader of the Lymphoma/Myeloma Cancer Center Program, Lavine Family Chair for Preventative Cancer Therapies, Director of the Ghobrial Lab, and Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School

Oncology

Boston, MA30+ years
Brian Wolpin

Brian Wolpin, M.D.

Director, Gastrointestinal Cancer Center; Director, Hale Family Center for Pancreatic Cancer Research

Oncology

Boston, MA20+ years
Peter Enzinger

Peter Enzinger, MD

Director, Center for Esophageal and Gastric Cancer; Associate Professor of Medicine, Harvard Medical School; Institute Physician

Oncology

Boston, MA30+ years
Rameen Beroukhim

Rameen Beroukhim, MD

Associate Professor of Medicine, Harvard Medical School

Oncology

Boston, MA20+ years
Lecia Sequist

Lecia Sequist, MD

Associate Professor of Medicine, Harvard Medical School; Mary B. Saltonstall Endowed Chair in Oncology, Massachusetts General Hospital Cancer Center

Oncology

Boston, MA20+ years
Alicia Morgans

Alicia Morgans, MD

Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported; Director, Survivorship Program

Oncology

Boston, MA20+ years
Frank Hodi

Frank Hodi, MD

Professor of Medicine, Harvard Medical School; Director, Melanoma Center and Center for Immuno-Oncology, Dana-Farber Brigham Cancer Center

Oncology

Boston, MA30+ years
Mary Frates

Mary Frates, MD

Professor of Radiology

Oncology

Boston, MA30+ years
Elad Sharon

Elad Sharon, M.D.

Director of the Immunotherapy Toxicity Program and a Member of the Faculty of Medicine at Harvard Medical School. From 2011 through August 2023, Dr. Sha

Oncology

Boston, MA20+ years

Browse oncologists accepting Curative by city

Drill into a specific Massachusetts city.

Frequently Asked Questions

How do I know these oncologists accept Curative?
Each profile on this page lists Curative among its accepted health plans. Plan participation can change — confirm directly with the practice before your visit.
What Curative plans do these oncologists accept?
Plan-level detail (PPO, HMO, EPO, Medicare Advantage, etc.) varies by specialists. Open a specific provider profile to see the exact Curative plans they've published as accepted.
What should I look for when picking a oncologist that takes Curative?
Start with clinical fit. Profiles on this page mention focus areas including Radiation Oncology, Medical Oncology, and Hematology & Oncology. Then verify the specific Curative plan you carry, compare credentials and affiliations, and check whether the profile mentions accepting new patients.
How do I narrow this list to my city?
Use the city links below to drill into a specific market — coverage and wait times vary by region even within the same state.
← Back to Oncologists accepting Curative nationwide